Expression, purification and characterization of C-FADD

Cellular and Molecular Immunology

Volumn 6, Issue 4, 2009, Pages 295-301

  Chen, Yuan ^a   Ma, Dingyuan ^a   Huang, Qi Lai ^a   Zheng, Weijuan ^a   Zhang, Jing ^a   Shen, Yi ^a   Li, Jiahuang ^a   Dong, Wei ^a   Lu, Min ^a   Wang, Jin ^a   Hua, Zi Chun ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

C FADD; Expression; Monomer; Purification

Indexed keywords

CASEIN KINASE IALPHA; FAS ASSOCIATED DEATH DOMAIN PROTEIN; GLUTARALDEHYDE; POLYHISTIDINE TAG; FADD PROTEIN, MOUSE; PEPTIDE FRAGMENT; FAS ASSOCIATED DEATH DOMAIN PROTEIN[80-205]; NICKEL; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN VARIANT; STRUCTURE ACTIVITY RELATION; AFFINITY CHROMATOGRAPHY; ANIMAL; APOPTOSIS; CIRCULAR DICHROISM; ESCHERICHIA COLI; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR CLONING; MOUSE; PROTEIN FOLDING; PROTEIN TERTIARY STRUCTURE; CELL STRAIN HEK293; EMBRYO; IN VITRO STUDY; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE;

ANIMALS; APOPTOSIS; CHROMATOGRAPHY, AFFINITY; CIRCULAR DICHROISM; CLONING, MOLECULAR; ESCHERICHIA COLI; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; MICE; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 69949148307     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2009.39     Document Type: Article

References (31)

1. Zhang JK, Cado D, Chen A, Kabra NH, Winoto A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature. 1998;392:296-300. (Pubitemid 28155104)
2. Yeh WC, de la Pompa JL, McCurrach ME, et al. FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science. 1998;279:954-1958.
3. Scaffidi C, Volkland J, Blomberg I, Hoffmann I, Krammer PH, Peter ME. Phosphorylation of FADD/MORT1 at serine 194 and association with a 70-kDa cell cycle-regulated protein kinase. J Immunol. 2000;164:1236-1242. (Pubitemid 30067235)
4. Barnhart BC, Lee JC, Alappat EC, Peter ME. The death effector domain protein family. Oncogene. 2003;22:8634-8644.
5. Zhang J, Winoto A. A mouse Fas-associated protein with homology to the human Mort1/FADD protein is essential for Fas-induced apoptosis. Mol Cell Biol. 1996;16:2756-2763. (Pubitemid 26163375)
6. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem. 1995;270:7795-7798.
7. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 1995;81:505-512.
8. Peter ME, Krammer PH. The CD95 (APO-1/Fas) DISC and beyond. Cell Death Differ. 2003;10:26-35.
9. Ashkenazi A, Dixit VM. Death receptors: Signaling and modulation. Science. 1998;281:1305-1308.
10. Krueger A, Baumann S, Krammer PH, Kirchhoff S. FLICE-inhibitory proteins: Regulators of death receptor-mediated apoptosis. Mol Cell Biol. 2001;21:8247-8254. (Pubitemid 33108586)
11. Werner MH, Wu CW, Walsh CM. Emerging roles for the death adaptor FADD in death receptor avidity and cell cycle regulation. Cell Cycle. 2006;5:2332-2338.
12. Walsh CM, Wen BG, Chinnaiyan AM, O'Rourke K, Dixit VM, Hedrick SM. A role for FADD in T cell activation and development. Immunity. 1998;8:439-449. (Pubitemid 28196798)
13. Kabra NH, Kang CH, Hsing LC, Zhang JK, Winoto A. T cell-specific FADD-deficient mice: FADD is required for early T cell development. Proc Natl Acad Sci U S A. 2001;98:6307-6312. (Pubitemid 32488235)
14. Alappat EC, Volkland J, Peter ME. Cell cycle effects by C-FADD depend on its C-terminal phosphorylation site. J Biol Chem. 2003;278:41585-41588. (Pubitemid 37310412)
15. Zhang J, Zhang DP, Hua ZC. FADD and its phosphorylation. IUBMB Life. 2004;56:395-401.
16. Hua ZC, Sohn SJ, Kang C, Cado D, Winoto A. A function of Fas-associated death domain protein in cell cycle progression localized to a single amino acid at its C-terminal region. Immunity. 2003;18:513-521. (Pubitemid 36513633)
17. Chinnaiyan AM, Tepper CG, Seldin MF, et al. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem. 1996;271:4961-4965.
18. Chinnaiyan AM, O'Rourke K, Yu GL, et al. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science. 1996;274:990-992. (Pubitemid 26398422)
19. Newton K, Harris AW, Bath ML, Smith KG, Strasser A. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 1998;17:706-718. (Pubitemid 28062050)
20. Hueber AO, Zornig M, Bernard AM, Chautan M, Evan G.. A dominant negative Fas-associated death domain protein mutant inhibits proliferation and leads to impaired calcium mobilization in both T-cells and fibroblasts. J Biol Chem. 2000;275:10453-10462. (Pubitemid 30202106)
21. Berglund H, Olerenshaw D, Sankar A, Federwisch M, McDonald NQ, Driscoll PC. The three-dimensional solution structure and dynamic properties of the human FADD death domain. J Mol Biol. 2000;302:171-188. (Pubitemid 30694429)
22. Carrington PE, Sandu C, Wei Y, et al. The structure of FADD and its mode of interaction with procaspase-8. Mol Cell. 2006;22:599-610. (Pubitemid 43817600)
23. Eberstadt M, Huang B, Chen Z, et al. NMR structure and mutagenesis of the FADD (Mort1) death-effector domain. Nature. 1998;392:941-945. (Pubitemid 28232068)
24. Jeong EJ, Bang S, Lee TH, Park YI, Sim WS, Kim KS. The solution structure of FADD death domain. Structural basis of death domain interactions of Fas and FADD. J Biol Chem. 1999;274:16337-16342. (Pubitemid 129526385)
25. Monteiro KM, Scapin SMN, Navarro MVAS, et al. Self-assembly and structural characterization of Echinococcus granulosus antigen B recombinant subunit oligomers. Biochim Biophys Acta-Proteins and Proteomics. 2007;1774:278-285.
26. Chen C, Huang QL, Jiang SH, Pan X, Hua ZC. Immobilized protein ZZ, an affinity tool for immunoglobulin isolation and immunological experimentation. Biotechnol Appl Biochem. 2006;45:87-92. (Pubitemid 44358594)
27. Li SF, Dong W, Zong YW, et al. Polyethylenimine-complexed plasmid particles targeting focal adhesion kinase function as melanoma tumor therapeutics. Mol Ther. 2007;15:515-523. (Pubitemid 46306594)
28. Pain R. Determining the CD spectrum of a protein. In: Current Protocols in Protein Science. John Wiley & Sons, Inc; 1996;7:1-23.
29. Alappat EC, Feig C, Boyerinas B, et al. Phosphorylation of FADD at serine 194 by CKI alpha regulates its nonapoptotic activities. Mol Cell. 2005;19:321-332. (Pubitemid 41074888)
30. Muppidi JR, Lobito AA, Ramaswamy M, Yang JK, Wang L, Wu H, Siegel RM. Homotypic FADD interactions through a conserved RXDLL motif are required for death receptor-induced apoptosis. Cell Death Differ. 2006;13:1641-1650. (Pubitemid 44390852)
31. Sandu C, Morisawa G, Wegorzewska I, et al. FADD self-association is required for stable interaction with an activated death receptor. Cell Death Differ. 2006;13:2052-2061. (Pubitemid 44742688)